QT Vascular secures US$12m convertible bond funding
Group signs agreement with private equity fund, three individual investors
Add BT as a preferred sourceDeeperDive is a beta AI feature. Refer to full articles for the facts.
Singapore
QT Vascular, a developer of minimally invasive products for the treatment of vascular diseases, has entered into an agreement with private equity fund ICH Gemini Asia Growth Fund and three individual investors for a US$12 million convertible bond investment.
This funding will allow QT Vascular to focus more resources on further developing its drug-coated Chocolate angloplasty balloon platform, which lowers acute trauma and is used to treat patients' coronary arteries, the group said in a statement.
Copyright SPH Media. All rights reserved.
TRENDING NOW
From 1MDB to ‘corporate mafia’: Is Malaysia facing a new governance test?
Middle East-linked energy supply shocks put Asean Power Grid back in focus
Beijing’s calculated silence on the Iran war
DPM Gan warns of 3 structural shifts to the global system that will bring greater challenges – and opportunities
